Canada · Delayed Price · Currency is CAD Sernova Biotherapeutics Statistics
Total Valuation
TSX:SVA has a market cap or net worth of CAD 66.88 million. The enterprise value is 71.24 million.
| Market Cap | 66.88M |
| Enterprise Value | 71.24M |
Important Dates
The next estimated earnings date is Wednesday, June 10, 2026.
| Earnings Date | Jun 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:SVA has 361.49 million shares outstanding. The number of shares has increased by 5.60% in one year.
| Current Share Class | 361.49M |
| Shares Outstanding | 361.49M |
| Shares Change (YoY) | +5.60% |
| Shares Change (QoQ) | +2.34% |
| Owned by Insiders (%) | 3.80% |
| Owned by Institutions (%) | 0.04% |
| Float | 347.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -2.61 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.75 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03
| Current Ratio | 0.03 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.38 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -376.96% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 50.31% |
| Weighted Average Cost of Capital (WACC) | 8.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.55M |
| Employee Count | 8 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -68,969 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.82% in the last 52 weeks. The beta is 0.63, so TSX:SVA's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +8.82% |
| 50-Day Moving Average | 0.16 |
| 200-Day Moving Average | 0.16 |
| Relative Strength Index (RSI) | 63.11 |
| Average Volume (20 Days) | 107,047 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.34M |
| Pretax Income | -12.45M |
| Net Income | -12.38M |
| EBITDA | -12.12M |
| EBIT | -12.34M |
| Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 576,221 in cash and 4.94 million in debt, with a net cash position of -4.37 million or -0.01 per share.
| Cash & Cash Equivalents | 576,221 |
| Total Debt | 4.94M |
| Net Cash | -4.37M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -25.60M |
| Book Value Per Share | -0.07 |
| Working Capital | -24.76M |
Cash Flow
| Operating Cash Flow | -7.13M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 213,498 |
| Net Borrowing | 4.86M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:SVA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.60% |
| Shareholder Yield | -5.60% |
| Earnings Yield | -18.52% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |